IP Library Granted Patent US 7,722,537
Granted Patent B2
US 7,722,537 · App. 11/314,173 · Granted May 25, 2010

Method and apparatus for detection of multiple analytes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,722,537
App. No.
11/314,173
Granted
May 25, 2010
Kind
B2
Abstract

An apparatus for analyzing the composition of bodily fluid. The apparatus comprises a fluid handling network including a patient end configured to maintain fluid communication with a bodily fluid in a patient and at least one pump intermittently operable to draw a sample of bodily fluid from the patient. The apparatus further comprises a fluid analyzer positioned to analyze at least a portion of the sample and measure the presence of two or more analytes. Also disclosed is a method for analyzing the composition of a bodily fluid in a patient. The method comprises drawing a sample of the bodily fluid of the patient through a fluid handling network configured to maintain fluid communication with a bodily fluid in a patient. The method further comprises analyzing the at least a portion of the sample in a fluid analyzer to estimate the concentration of two or more analytes in the sample.

Claims (39)

1. An apparatus for analyzing the composition of bodily fluid, the apparatus comprising:

a fluid handling network including a patient end configured to maintain fluid communication with a bodily fluid in a patient;

at least one pump in operative engagement with the fluid handling network, the at least one pump having a sample draw mode in which the pump is operable to draw a sample of the bodily fluid from the patient through the patient end;

a controller configured to operate the at least one pump in the sample draw mode at intervals;

a fluid analyzer positioned to analyze at least a portion of the sample;

a processor in communication with or incorporated into the fluid analyzer;

and stored program instructions executable by the processor to determine the concentrations of two or more analytes in the sample, wherein the program instructions are configured to cause the fluid analyzer to:

subject the at least a portion of the sample to one or more tests;

analyze results from the one or more tests to estimate the concentration of a first analyte;

determine whether the results from the one or more tests are sensitive to a second analyte in the sample; and

analyze the at least a portion of the sample to estimate the concentration of the second analyte, wherein analyzing the at least a portion of the sample comprises analyzing the same results from the one or more tests when it is determined that the results from spectral features of the second analyte overlap spectral features of the first analyte.

2. The apparatus of claim 1 , where said fluid analyzer analyzes the presence of at least one analyte in whole blood.

3. The apparatus of claim 1 , where said fluid analyzer analyzes the presence of at least one analyte in blood plasma.

4. The apparatus of claim 1 , where said fluid analyzer analyzes the presence of at least one analyte in blood serum.

5. The apparatus of claim 1 , where said fluid analyzer includes a spectroscopic analyzer.

6. The apparatus of claim 5 , where said spectroscopic analyzer is an infrared spectroscopic analyzer.

7. The apparatus of claim 5 , where said spectroscopic analyzer obtains a spectra of said at least a portion of the sample, and where said stored program instructions are further configured to cause the fluid analyzer to determine the presence of at least one of said two or more analytes from the spectra.

8. The apparatus of claim 7 , where said spectra includes spectral features of said two or more analytes.

9. The apparatus of claim 7 , where said spectra includes two or more spectra each including spectral features of one of said two or more analytes.

10. The apparatus of claim 1 , where one of said two or more analytes is glucose.

11. The apparatus of claim 1 , where at least one of said two or more analytes is a sugar.

12. The apparatus of claim 1 , where at least one of said two or more analytes is blood urea nitrogen (BUN), hemoglobin, or lactate.

13. The apparatus of claim 1 , where said bodily fluid is blood, and where said fluid analyzer accepts a sample of the bodily fluid from the fluid handling network and obtain a measurement of the hematocrit of the blood.

14. A method for automatically analyzing the composition of a bodily fluid in a patient, the method comprising:

a) automatically drawing a sample of the bodily fluid of the patient through a fluid handling network configured to maintain fluid communication with a bodily fluid in a patient;

b) directing at least a portion of the sample to a fluid analyzer connected to the fluid handling network;

c) obtaining a spectral characterization of at least a portion of the sample in the fluid analyzer;

d) analyzing the spectral characterization to estimate the concentration of a first analyte in the sample, the first analyte being apart from any interferents to the measurement of the first analyte;

e) determining whether a second analyte in the sample is associated with spectral features that overlap spectral features associated with the first analyte, the second analyte being apart from any interferents to the measurement of the second analyte;

f) analyzing the at least a portion of the sample to estimate the concentration of the second analyte, wherein analyzing the at least a portion of the sample comprises analyzing the spectral characterization when spectral features of the second analyte overlap spectral features of the first analyte;

g) automatically drawing another sample of the bodily fluid of the patient through the fluid handling network after an interval has elapsed; and

h) repeating steps b)-f) using the newly-drawn sample.

15. The method of claim 14 , where said portion includes whole blood, blood plasma, or blood serum.

16. The method of claim 14 , wherein said spectral characterization includes an infrared spectrum.

17. The method of claim 14 , where said spectral characterization includes spectral features of the first analyte and the second analyte.

18. The method of claim 14 , where one of the first analyte and the second analyte is glucose.

19. The method of claim 14 , where at least one of the first analyte and the second analyte is a sugar.

20. The method of claim 14 , where at least one of the first analyte and the second analyte is glucose, blood urea nitrogen (BUN), hemoglobin, or lactate.

21. The method of claim 14 , where said bodily fluid is blood, and said method further comprises obtaining a measurement of the hematocrit of the blood.

Assignments (6)
AMENDED AND RESTATED IP SECURITY AGREEMENT Recorded Feb 28, 2018
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 045469/0948 →
RELEASE OF SECURITY INTEREST Recorded Jan 11, 2017
From: HERCULES TECHNOLOGY II, L.P.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 041344/0534 →
CORRECTIVE ASSIGNMENT TO CORRECT THE GRANT OF SECURITY INCORRECTLY LISTED AS PATENT APPLICATION NUMBER 11314713 PREVIOUSLY RECORDED ON REEL 020995 FRAME 0202. ASSIGNOR(S) HEREBY CONFIRMS THE GRANT OF SECURITY IN PATENT APPLICATION NUMBER 11314173. Recorded Aug 26, 2015
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY II, L.P.
Reel/Frame 036472/0309 →
SECURITY AGREEMENT Recorded Dec 13, 2013
From: OPTISCAN BIOMEDICAL CORPORATION
To: EAST WEST BANK
Reel/Frame 031815/0377 →
SECURITY AGREEMENT Recorded May 23, 2008
From: OPTISCAN BIOMEDICAL CORPORATION
To: HERCULES TECHNOLOGY II, L.P.
Reel/Frame 020995/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2006
From: STERLING, BERNHARD B.; BRAIG, JAMES R.; RULE, PETER; HALL, W. DALE; WECHSLER, MARK; GABLE, JENNIFER H.
To: OPTISCAN BIOMEDICAL CORPORATION
Reel/Frame 017902/0072 →